Related Experiment Videos
[Diabetes Type I therapy through transplantation].
P Bucher1, Z Mathe, L H Buhler
1Département de chirurgie, service de chirurgie viscérale et de transplantation, hôpitaux universitaires de Genève, 24 rue Micheli-Du-Crest, 1211 Geneva 14, Switzerland. Pascal.Bucher@hcuge.ch
Annales De Chirurgie
|July 5, 2005
Summary
Insulin therapy for type 1 diabetes risks hypoglycemia. Pancreas or islet transplantation offers physiologic insulin replacement, restoring metabolic function and potentially preventing diabetic complications.
Area of Science:
- Endocrinology
- Transplantation immunology
- Metabolic diseases
Context:
- Diabetes mellitus is a prevalent chronic condition.
- Insulin therapy for type 1 diabetes (T1D) can lead to severe hypoglycemia.
- Restoring physiologic insulin metabolism is crucial for managing T1D.
Purpose:
- To review current knowledge on pancreatic and islet of Langerhans transplantation for T1D.
- To compare the efficacy and risks of these two transplantation methods.
- To highlight advancements in cell-based therapies for diabetes.
Summary:
- Pancreas transplantation and islet of Langerhans transplantation are established therapies for T1D.
- Both methods aim to restore endogenous insulin production.
- Insulin-producing Beta cells are the therapeutic target for transplantation.
Impact:
- Transplantation offers a potential cure for T1D by restoring normoglycemia.
- Understanding transplantation outcomes can guide future therapeutic strategies.
- Advances in transplantation may reduce the burden of diabetic complications.